Chinese drug developer Antengene wins backing from the likes of Boyu Capital and FountainVest Partners for a pipeline of treatments that address the country's growing cancer problem
Despite being the world’s second-largest pharmaceutical market, China isn’t known for its prowess in drug innovation. The country has some of the highest incidence rates for cancer, diabetes and liver...
Legend Capital sees Mancando's extensive network of brick-and-mortar outlets as the key to bringing greater supply chain efficiency to the Chinese auto parts industry
Advantage Partners has made its first acquisition in Vietnam, buying women’s fashion brand Elise Fashion for an undisclosed amount.
GIC Private has led a RMB850 million ($125.5 million) Series C round for Burning Rock, a Chinese cancer diagnostics start-up that is already working with hospitals on products based on DNA sequencing analysis.
Beacon Venture Capital, the VC unit of Thailand’s Kasikornbank, has led a $6.5 million investment in Jitta, a local financial technology provider and stock analysis platform operator.